April 18, 2022
3 mins read

RCSI Bahrain to find feasible cure for diabetes

The goal of the ongoing research led by the RCSI Bahrain research team is to find an alternative cure for diabetes that is more feasible…reports Asian Lite News

To address the prevalence of diabetes in Bahrain and the region, Professor Alexandra Butler, Senior Research Fellow and Lead of Diabetes & Islet Cell Biology research, and Professor Shahryar Khattak, Senior Research Scientist and Lead of Stem Cell & Genome Engineering research, from the Royal College of Surgeons in Ireland – Medical University of Bahrain (RCSI Bahrain) are collaborating on their ongoing research to explore the use of stem cells to find a feasible cure for diabetes.

Patients who suffer from diabetes have low numbers of beta cells (the cells in the pancreas that make insulin, a hormone that controls the blood glucose level) and therefore these patients have high levels of glucose in the blood. Treating these patients with insulin is essential for those with Type 1 diabetes and, together with other therapies, necessary for some patients with Type 2 diabetes; however, administration of insulin requires careful management and can have negative long term effects on a patient’s health.

To date, transplantation of either the entire pancreas or islets isolated from a pancreas, represent the only available cure option; such transplantation procedures have had varying degrees of success and still present multiple challenges, such as a lack of available donors and the need for life-long immunosuppression to avoid the immune system attacking and destroying the transplanted beta cells.

ALSO READ: Jackfruit flour, a new tool to control diabetes

The goal of the ongoing research led by the RCSI Bahrain research team is to find an alternative cure for diabetes that is more feasible in terms of the ease of the surgical procedure, compatibility with the patients’ health conditions, scalability to a larger number of patients and cost-effectiveness. Current research being developed at RCSI Bahrain will utilise beta cells derived from stem cells, which will be transplanted within an encapsulation device.

RCSI Bahrain is collaborating with a UK-based company to develop novel encapsulation devices using a range of biomaterials as a preferred option, due to their availability in large quantities and cost-effectiveness. An ideal encapsulation device must protect the cells from the autoimmune attack, must not cause a foreign body reaction or lead to the development of fibrosis and provide a suitable environment in which the cells can survive and function, all of which are offered by the developed biomaterial technology.

Professor Stephen Atkin, Head of School of Postgraduate Studies and Research, who also oversees the RCSI Bahrain Clinical and Biomolecular Research Centre and all research initiatives: “The collaborative research being undertaken by Professor Alexandra Butler and Professor Shahryar Khattak in developing a cure for diabetes is a research priority at the Research Centre, where contributing to the development of a cure will be a major step in the lives of diabetic patients and advancing their quality of life.”

Experiments conducted by Professor Butler and her team at the RCSI Bahrain Clinical and Biomolecular Research Centre, to test the use of biomaterials both in vitro and in vivo, showed that the use of biomaterials did not affect cell viability or function in vitro, nor did they cause inflammation or fibrosis in vivo, making these biomaterials a potentially excellent solution for cell-encapsulation.

ALSO READ:

The second area of the ongoing research to find a cure for diabetes is led by Professor Khattak, who is working with his team at the Stem Cells & Genome Engineering Unit, to produce stem-cell derived beta cells, which Professor Butler will use for the encapsulation devices. By using human pluripotent stem cells​, Professor Khattak and his team were able to generate pancreatic beta cells, which were functional and able to produce insulin when checked for responsiveness to glucose. ​

Although there are limitations to the current stem cell to beta cell protocols, the next steps of the ongoing research will be to design a human-compatible encapsulation device for transplantation and explore the potential of the combined procedure in potential human clinical trials.​

​The RCSI Bahrain Clinical and Biomolecular Research Centre promotes teaching and research focused on the national healthcare priorities with the mission to specifically address prevalent health conditions and health diseases in Bahrain and beyond.

Previous Story

Acer marks 30 years of success in MEA region

Next Story

Six killed, 11 injured as Russian missiles pound Lviv

Latest from Arab News

Relief Rolls In, Restrictions Remain in Gaza

Israeli official noted an Israeli statement saying it would limit the number of aid truckloads entering the Gaza Strip to 300 daily…reports Asian Lite News Relief operations in Gaza have intensified since

‘A Day to Rejoice’

In its statement, British Friends of Israel saluted the courage and resilience of the hostages and expressed deep sorrow for those who did not survive captivity After 737 days of anguish, the

UK to Lead Gaza Rebuild

PM announces an additional £20 million aid package aimed at providing essential water, sanitation and hygiene services to tens of thousands of people Prime Minister Keir Starmer attended the signing ceremony of

Gaza Truce Signed, Key Players Missing

Sisi reiterated support for the implementation of the Gaza ceasefire plan, stressing that the agreement must be “solidified and all its phases implemented…reports Asian Lite News A document formalising the recently brokered

Hamas Frees Captives

The Israeli Air Force announced that it has completed its preparations to receive hostages returning from Gaza to Israel….reports Asian Lite News The Red Cross has taken custody of the first group
Go toTop

Don't Miss

Israeli archaeologists discover 3,300-year-old lead amulet

Israeli archaeologists have discovered a lead amulet with ancient Hebrew

UN envoy in Yemen’s Aden to discuss reopening of Taiz

UN Special Envoy for Yemen, Hans Grundberg arrived in the